• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Subcutaneous vs Intravenous Administration of Medications and Fluids for Patients With Cancer in the US and Canada.美国和加拿大癌症患者皮下与静脉给药及输液情况
JAMA Oncol. 2023 May 1;9(5):717-719. doi: 10.1001/jamaoncol.2023.0239.
2
Variables Associated With Intravenous Rehydration and Hospitalization in Children With Acute Gastroenteritis: A Secondary Analysis of 2 Randomized Clinical Trials.急性胃肠炎患儿静脉补液与住院相关的变量：两项随机临床试验的二次分析。
JAMA Netw Open. 2021 Apr 1;4(4):e216433. doi: 10.1001/jamanetworkopen.2021.6433.
3
Inappropriate medication administration practices in Canadian adult ICUs: a multicenter, cross-sectional observational study.加拿大成人 ICU 中不当的药物管理实践：一项多中心、横断面观察性研究。
Ann Pharmacother. 2013 May;47(5):637-43. doi: 10.1345/aph.1R414. Epub 2013 Apr 19.
4
Quality of care in the course of subcutaneous versus intravenous trastuzumab administration in patients with breast cancer: an integrated time-motion study with mixed-methods research.在乳腺癌患者中皮下与静脉注射曲妥珠单抗给药过程中的护理质量：一项混合方法研究的整合时间与动作研究。
BMJ Open. 2023 Mar 16;13(3):e059288. doi: 10.1136/bmjopen-2021-059288.
5
[A PROPOSED NEW SYSTEM FOR SUBCUTANEOUS OR INTRAVENOUS ADMINISTRATION OF FLUIDS].[一种提议的用于皮下或静脉内输注液体的新系统]
Sveikatos Apsauga. 1963 May;8:50-1.
6
[Histologic study of the kidney after rapid intravenous administration of fluids].[快速静脉输注液体后肾脏的组织学研究]
Boll Soc Ital Biol Sper. 1959 Dec 30;35:1694-8.
7
Assessment of Subcutaneous vs Intravenous Administration of Anti-PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation Trial.评估抗 PD-1 抗体 PF-06801591 皮下注射与静脉注射用于晚期实体瘤患者：一项 I 期剂量递增试验。
JAMA Oncol. 2019 Jul 1;5(7):999-1007. doi: 10.1001/jamaoncol.2019.0836.
8
A trocar and cannula for the intravenous administration of fluids.一种用于静脉输液的套管针。
Med J Aust. 1946 May 4;1:629.
9
Pharmacokinetics of teceleukin (recombinant human interleukin-2) after intravenous or subcutaneous administration to patients with cancer.特西白细胞介素（重组人白细胞介素-2）对癌症患者静脉或皮下给药后的药代动力学。
J Biol Response Mod. 1989 Aug;8(4):440-9.
10
Continuous subcutaneous delivery of medications for home care palliative patients-using an infusion set or a pump?居家姑息治疗患者皮下持续输注药物——使用输液套件还是输注泵？
Support Care Cancer. 2010 Sep;18(9):1165-70. doi: 10.1007/s00520-009-0736-x. Epub 2009 Sep 30.

引用本文的文献

1
Proportional Sedation for Persistent Agitated Delirium in Palliative Care: A Randomized Clinical Trial.姑息治疗中持续性激越性谵妄的比例镇静：一项随机临床试验。
JAMA Oncol. 2025 Jul 31. doi: 10.1001/jamaoncol.2025.2212.
2
Real-World Quantitative Insights into the Treatment Experience of Patients with Cancer in the USA with Subcutaneous Versus Intravenous Drug Delivery.对美国癌症患者皮下给药与静脉给药治疗体验的真实世界定量洞察。
Oncol Ther. 2025 Jul 16. doi: 10.1007/s40487-025-00360-4.
3
Stick With Intravenous or Give Subcutaneous a Shot? Time and Other Considerations When Evaluating Cancer Drug Formulations.坚持静脉注射还是尝试皮下注射？评估癌症药物制剂时的时间及其他考量因素。
JCO Oncol Pract. 2025 Mar;21(3):267-269. doi: 10.1200/OP-24-00501. Epub 2024 Aug 2.
4
Practice efficiency and total cost of care with bispecifics and CAR-T in relapsed/refractory diffuse large B-cell lymphoma: an institutional perspective.双特异性抗体和嵌合抗原受体 T 细胞治疗复发/难治性弥漫性大 B 细胞淋巴瘤的实践效率和总医疗成本：机构视角。
Future Oncol. 2024;20(29):2189-2201. doi: 10.1080/14796694.2024.2354157. Epub 2024 Jun 24.

Subcutaneous vs Intravenous Administration of Medications and Fluids for Patients With Cancer in the US and Canada.

作者信息

Tang Michael, Abdelaal Mohamed, Lau Jenny, Ruiz Buenrostro Alejandra, Chen Minxing, Zimmermann Camilla, Bruera Eduardo

机构信息

Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston.

The Ottawa Hospital Research Institute, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

出版信息

JAMA Oncol. 2023 May 1;9(5):717-719. doi: 10.1001/jamaoncol.2023.0239.

DOI:10.1001/jamaoncol.2023.0239
PMID:36951869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10037196/
Abstract
摘要